Friday, May 20, 2022
    HomeHealthSTAT+: Pharmalittle: Chinese authorities summon AstraZeneca execs over insurance fraud; Lilly to...

    STAT+: Pharmalittle: Chinese authorities summon AstraZeneca execs over insurance fraud; Lilly to invest $1.5B in two factories



    Good morning, everybody, and welcome to a different working week. We hope the weekend respite was by some means invigorating and stress-free, regardless of the storm that battered some elements. As for us, we efficiently returned from depositing our shortest individual at an establishment of upper studying simply in time to retrieve our shovel from the instrument shed. And so, we are going to rejoice with a well-earned cup or three of stimulation. Our alternative at this time is stroopwafel. Sure, it is a actual factor. So be happy to affix us. In the meantime, we’ve assembled one other lineup of attention-grabbing objects to hopefully jumpstart your day. Hope all goes effectively and, as at all times, do be in contact. We take pleasure in your postcards and telegrams …

    The marketplace for biotech expertise in Massachusetts has lengthy been strong, however these days the crunch has turned essential, because the pipeline of certified staff to fill all the added jobs can’t sustain with the burgeoning demand, The Boston Globe writes. And that is inflicting some within the business to fret that it’ll not solely inhibit development, but additionally have an effect on the standard of labor as key positions turn into more durable to fill and lower-level staff soar from firm to firm looking for a greater compensation bundle. Worker turnover is on the rise, too. About 16.5% of life sciences staff in Massachusetts voluntarily give up their jobs final 12 months, up from 13% in 2018.

    Continue to STAT+ to read the full story…


    Source link

    Related articles

    Stay Connected


    Latest posts